Cornerstone Capital Management Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$895K	Buy	+13,900	New	+$865K	0.01%	920
2017 Q1	–	Sell	-2,200	Closed	-$133K	–	1290
2016 Q4	$133K	Sell	2,200 -7,800	-78%	-$477K	﹤0.01%	1227
2016 Q3	$663K	Buy	+10,000	New	+$625K	﹤0.01%	1025
2016 Q1	–	Sell	-3,500	Closed	-$158K	–	1486
2015 Q4	$158K	Buy	+3,500	New	+$151K	﹤0.01%	1252
2015 Q3	–	Sell	-1,100	Closed	-$68K	–	1490
2015 Q2	$68K	Sell	1,100 -800	-42%	-$47.6K	﹤0.01%	1332
2015 Q1	$119K	Buy	+1,900	New	+$116K	﹤0.01%	1248
2014 Q4	–	Sell	-23,000	Closed	-$651K	–	1256
2014 Q3	$651K	Buy	+23,000	New	+$689K	0.01%	939

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cornerstone Capital Management Holdings's ANIP Position: Q4 2017 in Review

Cornerstone Capital Management Holdings opened a new position in ANI Pharmaceuticals (ANIP) in Q4 2017: 13,900 shares worth $895K. The stake represents 0.01% of the portfolio and ranks #920 among its holdings. This is a return to the name: Cornerstone Capital Management Holdings previously reported a position in ANIP as recently as Q4 2016.

Cornerstone Capital Management Holdings first reported a position in ANIP in Q3 2014 and has held it in 7 quarters since. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

Cornerstone Capital Management Holdings held 13,900 shares of ANI Pharmaceuticals worth $895K as of Q4 2017.
ANI Pharmaceuticals was a new Cornerstone Capital Management Holdings position in Q4 2017.
ANI Pharmaceuticals made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #920 holding.
Cornerstone Capital Management Holdings first reported a position in ANI Pharmaceuticals in Q3 2014 and has held it in 7 quarters since.
163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.